Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DX25F6AGT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,565
Award facts
- Contract value 100% obligated
- $25,564.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,564.66 on September 22, 2025, for the supply of Alecensa 150 mg capsules (240-unit packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, carries no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the company's Park Ridge, Illinois location.
Alecensa (alectinib) is an oral anaplastic lymphoma kinase inhibitor used in oncology treatment, making this delivery order part of the broader federal pharmaceutical supply chain supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier for specialized pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to military health facilities across the nation. The company's consistent success in securing delivery orders without set-aside designations demonstrates its competitive positioning within federal procurement markets while leveraging its woman-owned small business status.
Quick answers
Who was awarded contract SPE2DX25F6AGT?
SPE2DX25F6AGT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6AGT worth?
The government has obligated $25,565 on SPE2DX25F6AGT.
Is contract SPE2DX25F6AGT an order under another contract?
Yes. SPE2DX25F6AGT is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGT competed?
The extent of competition for SPE2DX25F6AGT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award